pharmaceutical

Showing 15 posts of 792 posts found.

brexit-referendum-uk-1468255193y2p

What pharma should know about the European Unitary Patent in light of Brexit

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, biotech, brexit, drugs, healthcare, pharma, pharmaceutical

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty. Two Brexit-related …

aedes_aegypti_mosquito

20 million mosquitoes to be released to limit population

July 17, 2017
Research and Development, Sales and Marketing Novartis, Verily, biotech, drugs, google, pharma, pharmaceutical

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

FDA refuses approval of Amgen osteoporosis drug

July 17, 2017
Sales and Marketing Amgen, Evenity, Radial, UCB, biotech, drugs, osteoporosis, pharma, pharmaceutical

Amgen and its development partner UCB have announced that the FDA has issued a complete response letter for the biologics …

pascal_soriot

AstraZeneca’s Soriot Teva switch scotched

July 17, 2017
Medical Communications, Sales and Marketing AstraZeneca, Soriot, Teva, biotech, drugs, pharma, pharmaceutical

The rumours, beginning with a report by Israeli newspaper Calcalist, had suggested that Pascal Soriot, CEO of AstraZeneca, appeared to …

UK government announces £86 million funding as tentative AAR step

July 14, 2017
Medical Communications NHS, UK government, biotech, drugs, pharma, pharmaceutical

The UK government has revealed that it will apportion £86 million to help the assessment of new technologies and increase …

document-428331_960_720

Independent panel advise FDA to apply different framework to opioid painkillers

July 14, 2017
Medical Communications FDA, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Over a year ago, the Obama administration asked the National Academies of Sciences, Engineering, and Medicine to advise them on …

J&J uses FDA Priority Review Voucher to snag psoriasis approval

July 14, 2017
Medical Communications, Sales and Marketing Janssen, Johnson & Johnson, Tremfya, biotech, drugs, pharma, pharmaceutical

The FDA has handed out another approval, as the agency now easily surpasses last year’s figure of 22 already, this …

blood-1813410_960_720

Heart scan offers possibility of non-invasive diagnosis

July 13, 2017
Medical Communications, Research and Development biotech, cardiovascular, drugs, heart, heart scan, pharma, pharmaceutical

Scientists from the University of Oxford have developed a heart scan that can identify inflammation around arteries that can suggest …

wave_logo

Gain insight into what your peers are doing

July 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, life sciences, pharma, pharmaceutical, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

shutterstock_103378880

UK Government boosts NHS cyber security with additional £21 million

July 13, 2017
Medical Communications Cyber Security, Cyber attack, NHS, biotech, drugs, life sciences, pharma, pharmaceutical

The government has announced its response to Dame Fiona Caldicott’s 2016 data security review and in the wake of the …

Novartis’ breakthrough cancer treatment receives FDA advisory approval

July 13, 2017
Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

pascal_soriot

AstraZeneca’s CEO set for shock switch to Teva

July 13, 2017
Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

Ocular slapped with CRL despite last-ditch efforts

July 12, 2017
Dextenza, Ocular Therapeutix, biotech, drugs, pharma, pharmaceutical

Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …

The Gateway to Local Adoption Series

Latest content